HCQS – Our churn out product to fight against Covid-19
18 April 2020
TIL Healthcare, the international pharmaceutical arm of the Jhaver Group, at its formulation manufacturing facility, is all set to produce Hydroxychloroquine Sulfate (HCQS) Tablets, for which it has obtained a licence from the government.
